No DIET Trial: Dogmatic Interruption of Enteral NuTrition
Launched by JEFFREY COUGHENOUR · May 24, 2024
Trial Information
Current as of February 12, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The risk for malnutrition-associated complications is high for patients in the trauma- surgical-, and neurological intensive care units. Patients with persistent neurologic impairment often require nutritional supplementation through a variety of naso-enteral or surgical feeding tubes such as percutaneous endoscopic gastrostomy (PEG) tubes. In patients with a protected airway, enteral nutrition has been reported to continue during invasive surgical procedures. Nonetheless, University Hospital's current SOC for holding enteral nutrition prior to undergoing surgical procedures under anesthesi...
Gender
ALL
Eligibility criteria
- Inclusion criteria:
- • Patients aged \>18 years.
- • Patients who require a tracheostomy or PEG placement.
- Exclusion criteria:
- • Patients with gastric and/or bowel obstruction.
- • Patients unable to receive enteral nutrition.
- • Patients who are pregnant and/or breastfeeding.
Trial Officials
Jeffrey Coughenour, MD
Principal Investigator
University of Missouri-Columbia
About Jeffrey Coughenour
Jeffrey Coughenour is a dedicated clinical trial sponsor known for his commitment to advancing medical research and improving patient outcomes. With a strong background in clinical operations and trial management, he specializes in overseeing the development and execution of innovative clinical studies across various therapeutic areas. His leadership is characterized by a strategic approach to trial design, regulatory compliance, and stakeholder engagement, ensuring that projects are conducted efficiently and ethically. Jeffrey's passion for enhancing healthcare solutions is reflected in his collaborative efforts with research institutions and healthcare professionals, driving progress in the clinical research landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Columbia, Missouri, United States
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0